Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$305M |
| 2 |
Prologis
PLD
|
+$97.9M |
| 3 |
Carlisle Companies
CSL
|
+$29.2M |
| 4 |
Healthcare Realty
HR
|
+$28.7M |
| 5 |
Gaming and Leisure Properties
GLPI
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$91.2M |
| 3 |
Chevron
CVX
|
+$54.7M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$52.9M |
| 5 |
Microsoft
MSFT
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Industrials | 8.88% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
SPX Corp
SPXC
$10.6B
| $5.99M | ﹤0.01% |
108,418
+1,100
| +1% | +$63K |
|
1177
Glaukos
GKOS
$11.2B
| $5.97M | ﹤0.01% |
112,200
+1,400
| +1% | +$72.2K |
|
1178
Prestige Consumer Healthcare
PBH
$2.43B
| $5.94M | ﹤0.01% |
119,200
+800
| +0.7% | +$44.3K |
|
1179
Rapid7
RPD
$929M
| $5.93M | ﹤0.01% |
138,200
+1,300
| +0.9% | +$80.2K |
|
|
NVMI
1180
Nova
NVMI
$13.1B
| $5.91M | ﹤0.01% |
68,667
+823
| +1% | +$80.9K |
|
1181
Herc Holdings
HRI
$5.64B
| $5.89M | ﹤0.01% |
56,746
+800
| +1% | +$89K |
|
1182
Albany International
AIN
$1.82B
| $5.89M | ﹤0.01% |
74,700
-300
| -0.4% | -$25.8K |
|
1183
Innovative Industrial Properties
IIPR
$1.67B
| $5.87M | ﹤0.01% |
66,300
+6,000
| +10% | +$582K |
|
1184
Yeti Holdings
YETI
$3.44B
| $5.83M | ﹤0.01% |
204,300
-2,400
| -1% | -$100K |
|
|
SEM
1185
DELISTED
Select Medical
SEM
| $5.82M | ﹤0.01% |
488,685
-8,723
| -2% | -$124K |
|
1186
TAL Education Group
TAL
$6.43B
| $5.82M | ﹤0.01% |
1,177,965
+35,400
| +3% | +$176K |
|
1187
Corcept Therapeutics
CORT
$11.9B
| $5.81M | ﹤0.01% |
226,765
+2,100
| +0.9% | +$56.2K |
|
1188
Alpha Metallurgical Resources
AMR
$1.97B
| $5.78M | ﹤0.01% |
42,200
+600
| +1% | +$83.4K |
|
|
VSXY
1189
Victoria's Secret
VSXY
$7.24B
| $5.77M | ﹤0.01% |
198,100
-10,800
| -5% | -$364K |
|
1190
Plexus
PLXS
$7.04B
| $5.75M | ﹤0.01% |
65,700
-500
| -0.8% | -$44.6K |
|
1191
Forward Air
FWRD
$682M
| $5.75M | ﹤0.01% |
63,700
+200
| +0.3% | +$19.6K |
|
|
HBI
1192
DELISTED
Hanesbrands
HBI
| $5.75M | ﹤0.01% |
825,700
| – | – |
|
1193
Shoals Technologies Group
SHLS
$1.37B
| $5.74M | ﹤0.01% |
266,500
+20,100
| +8% | +$449K |
|
|
TRQ
1194
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $5.74M | ﹤0.01% |
192,410
+1,500
| +0.8% | +$40.8K |
|
|
DNB
1195
DELISTED
Dun & Bradstreet
DNB
| $5.74M | ﹤0.01% |
463,200
+6,200
| +1% | +$92K |
|
1196
International Bancshares
IBOC
$4.57B
| $5.73M | ﹤0.01% |
134,800
+400
| +0.3% | +$17.1K |
|
1197
Pacira BioSciences
PCRX
$924M
| $5.73M | ﹤0.01% |
107,700
+2,400
| +2% | +$133K |
|
1198
10x Genomics
TXG
$7.58B
| $5.71M | ﹤0.01% |
200,500
+2,500
| +1% | +$95.2K |
|
1199
MaxLinear
MXL
$6.95B
| $5.7M | ﹤0.01% |
174,773
+2,400
| +1% | +$88.7K |
|
1200
Yelp
YELP
$1.32B
| $5.7M | ﹤0.01% |
168,064
-4,600
| -3% | -$152K |
|
Similar funds
Swiss National Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
- Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
- Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
- Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
- Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
- Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
- Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.
Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.